A bioinspired enantioselective synthesis of crinine-type alkaloids has been developed by iridium-catalyzed asymmetric hydrogenation of racemic cycloenones. The method features a biomimetic stereodivergent resolution of the substrates bearing a remote arylated quaternary stereocenter. Using this protocol, 24 crinine-type alkaloids and 8 analogues were synthesized in a concise and rapid way with high yield and high enantioselectivity.
Introduction
Amaryllidaceae alkaloids have long attracted the attention of synthetic chemists due to their signicant bioactivities such as antitumor, antiviral, and anti-acetylcholinesterase activities, and the fascinating diversity of their structures. To date, more than 500 Amaryllidaceae alkaloids have been isolated from Amaryllidaceae plants.
1 However, only one member of them, galanthamine, has been approved as a prescription drug for the treatment of Alzheimer's disease.
2 Because these alkaloids are structurally intricate, general methods for their synthesis are lacking, which has hindered the study of their medicinal chemistry.
We recently became particularly interested in crinine-type alkaloids, a large subclass (more than 80 have been isolated) of the Amaryllidaceae alkaloid family, that possess an antipodal chiral 5,10b-ethanophenanthridine core skeleton with a benzylic all-carbon quaternary centre 1c (Fig. 1 ). For example, the parent alkaloid of the subclass, (À)-crinine, was rst isolated in 1955 from the bulbs of two unidentied Crinum species from South Africa; 3 (+)-vittatine, which has the opposite conguration to that of (À)-crinine, is another crinine-type alkaloid.
4 Importantly, the crinine-type alkaloids are considered to be biogenic precursors of several types of Amaryllidaceae alkaloids including tazettine-, haemanthamine-, and narciclasine-type alkaloids 5 ( Fig. 1) . Thus, exploring efficient methods for the rapid synthesis of diverse crinine-type alkaloids is particularly important and desirable. However, although great efforts have been devoted to the development of synthetic methods to obtain crinine-type alkaloids, most of the reported approaches provided racemic products.
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We noticed that some Amaryllidaceae species can produce two similar alkaloids with enantiomeric skeletons. For example, both (À)-crinine and (+)-epivittatine have been isolated simultaneously from the bulbs of Nerine bowdenii, Boophane ava, and Crinum moorei (Scheme 1a). 4b,9 Inspired by this natural phenomenon and the biosynthetic pathway of crinine-type alkaloids, we envisaged a new synthetic strategy that mimics the enzymatic reduction resolution of racemic oxocrinines 1 using synthetic chiral catalysts (Scheme 1b). Because racemic oxocrinines 1 can be prepared in only four steps in high yields by a biomimetic intramolecular phenolic oxidative coupling of O-methylnorbelladine derived from L-phenylalanine and Ltyrosine, 6f this asymmetric catalytic stereodivergent resolution 
Results and discussion
Although asymmetric hydrogenation of the ketone group of a,bunsaturated ketones is an efficient way for synthesising optically active allylic alcohols, 11 the asymmetric hydrogenation of cyclohexenones with no substituent at the a-position is still a challenge (Scheme 1c).
12 To nd efficient chiral catalysts for the asymmetric hydrogenation of racemic oxocrinines 1, we investigated chiral spiro iridium catalysts Ir-SpiroPAP (3) 13 developed in our laboratory. The racemic oxocrinines 1 were prepared in four steps with 55-66% yield from commercially available starting materials using Node's biomimetic procedure 6f (see the ESI †). Asymmetric hydrogenation of rac-1a (R 1 , the enantiomeric excess (ee) of the major product (+)-trans-2a was only 27% (Table 1, entry 1). A comparison of the various IrSpiroPAP catalysts showed that (R)-3d, containing P(3,5-di-tertbutylphenyl) 2 groups and a 3-Me-pyridine moiety, is the best catalyst, which afforded the products (À)-cis-2a and (+)-trans-2a in 93% yield with 97% ee and 87% ee, respectively, in a ratio of 45 : 55 (entry 4). The effect of solvent was examined, and nPrOH gave comparable results to EtOH (entry 8). In addition to KOtBu, other bases such as KOH, K 2 CO 3 and Et 3 N can also be used, although the reaction with Et 3 N needs a longer time for completion and the yield is lower (entry 11). Further study of the reaction temperature, base concentration, hydrogen pressure, and co-solvent established the optimal reaction conditions to be as follows: 0.1 mol% (R)-3d, [rac-1a] Codina's protocol, 14 but it was demonstrated to be difficult. Fortunately, we found that the mixture can be isolated by converting them into benzoyl esters, and aer hydrolysis of the isolated benzoyl esters (À)-cis-2a and (+)-trans-2a can be obtained in pure form with high yield.
Using this bioinspired asymmetric hydrogenation stereodivergent resolution method, a range of crinine-type alkaloids Table 2 Asymmetric syntheses of crinine-type alkaloids and analogues by hydrogenation of rac-1 catalyzed by (R)-3d and (S)-3d C, 100% conversion. The cis/trans ratio was determined by 1 H NMR. The products were obtained by converting them into benzoyl esters, followed by chromatography on silica gel and hydrolysis of the resulting isolated products with NaOH aqueous solution. The ee values of the products were determined by chiral HPLC analysis of the corresponding benzoyl esters. All the yields are isolated yields. and analogues were synthesized from the corresponding racemic oxocrinines 1 (Table 2) . In each reaction, two crininetype alkaloids or analogues were obtained in high yield with high enantioselectivity. The absolute congurations of the products were determined by the conguration of the catalyst.
The Ir-SpiroPAP-catalyzed asymmetric hydrogenation of oxocrinines 1 could be performed on a multigram scale (Scheme 2). For example, hydrogenation of substrates rac-1a and rac-1c on a 2 g scale produced ( 
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The methylation of the hydroxy group of the alkaloids 2 can offer O-methyl crinine-type alkaloids. When (À)-cis-2a and (À)-cis-2d were treated with TMSCH 2 N 2 (trimethylsilyl diazomethane) in the presence of HBF 4 in DCM, another two alkaloids, (À)-buphanisine and (À)-buphanidrine, 21 were obtained in 62% and 68% yield, respectively (Scheme 3). According to Guillou's procedure, 6j,22 (À)-trans-2a was successfully oxidized with peroxymidic acid generated in situ from CCl 3 CN/H 2 O 2 to the epoxide 4 in 68% yield in the presence of triuoroacetic acid. A Mitsunobu reaction converted the epoxide 4 to the benzoate, followed by the removal of the benzoyl group with LiAlH 4 , yielding (À)-exinine 23 in 60% yield (2 steps). The (À)-exinine was reacted with TMSCH 2 N 2 in the presence of HBF 4 in DCM to produce (À)-augustine in 69% yield. Thus, the enantioselective syntheses of (À)-buphanisine, (À)-buphanidrine, (À)-exinine, and (À)-augustine were also achieved.
Conclusions
In conclusion, we have developed a bioinspired strategy for the rapid enantioselective synthesis of crinine-type alkaloids. This strategy features an iridium-catalyzed asymmetric hydrogenation of racemic cycloenones with a remote arylated quaternary stereocenter via stereodivergent resolution. Using this new strategy, we synthesized a total of 24 crinine-type alkaloids and 8 analogues in 7.9-29.4% yields in only ve or nine steps (seven or eleven steps including the esterication and hydrolysis in the separation of the hydrogenation products). Among these crinine-type alkaloids, seven have been previously synthesized with 8-20 steps in 0.6-13.2% yields (see also ESI †). 
